Clinical applications of dendritic cell vaccination in the treatment of cancer Lee D. CranmerKatrina T. TrevorEvan M. Hersh Review 26 November 2003 Pages: 275 - 306
Her-2/neu altered peptide ligand–induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction Sara O. DionneCheryl E. MyersDouglas F. Lake Original Article 05 November 2003 Pages: 307 - 314
Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I–mediated antitumor immunity Kwang-Woon KimSun-Hee KimChi-Dug Kang Original Article 18 December 2003 Pages: 315 - 322
Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity Stephen M. TodrykJonathan EatonHardev S. Pandha Original Article 28 November 2003 Pages: 323 - 330
Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA Gustav J. UllenhagJan FagerbergHåkan Mellstedt Original Article 07 November 2003 Pages: 331 - 337
Growth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexes Robert J. HigginsMaureen McKisicRichard A. LeCouteur Original Article 13 November 2003 Pages: 338 - 344
A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity Kimberlyn F. CardShari A. Price-SchiaviHing C. Wong Original Article 11 November 2003 Pages: 345 - 357
Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells Lola WeissReuven OrAli Abdul-Hai Original Article 05 November 2003 Pages: 358 - 362
Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice Witold LasekGrzegorz BasakMarek Jakóbisiak Original Article 07 November 2003 Pages: 363 - 372
